E-ISSN 2148-5607
RELATED ARTICLES
Editorial
Effects of a long-acting somatostatin analogue, lanreotide, on bile duct ligation-induced liver fibrosis in rats
(Turk J Gastroenterol 2010; 21: 287-292)
DOI: 10.4318/tjg.2010.0102
Daily consensus interferon (CIFN) monotherapy in non-responders or relapsers to a previous interferon regime: One year follow-up after 48 weeks of treatment
(Turk J Gastroenterol 2006; 17: 35-39)
The efficacy of pegylated interferon alpha 2a or 2b plus ribavirin in chronic hepatitis C patients
(Turk J Gastroenterol 2006; 17: 94-98)
Predictive value of proliferating cell nuclear antigen index in response to interferon treatment in patients with chronic viral hepatitis B and C
(Turk J Gastroenterol 2001; 12: 89-94)
Transmission routes of chronic hepatitis C and their relation to HCV genotypes
(Turk J Gastroenterol 2010; 21: 396-400)
DOI: 10.4318/tjg.2010.0126
HCV genotypes in HCV related chronic hepatitis in Southeast Anatolia
(Turk J Gastroenterol 1999; 10: 249-252)
Case Report
Alström syndrome with liver cirrhosis: First case from Turkey
(Turk J Gastroenterol 2013; 24: 546-548)
DOI: 10.4318/tjg.2013.0587
Original Article
Simple non-invasive markers as a predictor of fibrosis and viral response in chronic hepatitis C patients
(Turk J Gastroenterol 2012; 23: 538-545)
DOI: 10.4318/tjg.2012.0358
AST-platelet ratio index, Forns index and FIB-4 in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis C
(Turk J Gastroenterol 2011; 22: 279-285)
DOI: 10.4318/tjg.2011.0213
The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study
(Turk J Gastroenterol 2014; 25: 63-68)
DOI: 10.5152/tjg.2014.6233
Carotid intima-media thickness and flow-mediated dilation in obese children with non-alcoholic fatty liver disease
(Turk J Gastroenterol 2014; 25: 92-98)
DOI: 10.5152/tjg.2014.5552
Relationship between Helicobacter pylori infection and metabolic syndrome
(Turk J Gastroenterol 2015; 26: 468-473)
DOI: 10.5152/tjg.2015.0197
The relationship between serum adiponectin and resistin levels, insulin resistance and colorectal adenomas
(Turk J Gastroenterol 2015; 26: 20-24)
DOI: 10.5152/tjg.2015.3626
Can eicosapentaenoic acid maintain the original ribavirin dose or affect the response during the treatment course of chronic hepatitis C virus (HCV) patients?
(Turk J Gastroenterol 2016; 27: 55-61)
DOI: 10.5152/tjg.2015.150280
The predictive value of noninvasive serum markers of liver fibrosis in patients with chronic hepatitis C
(Turk J Gastroenterol 2016; 27: 156-164)
DOI: 10.5152/tjg.2015.150449
Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease
(Turk J Gastroenterol 2016; 27: 361-366)
DOI: 10.5152/tjg.2016.16106
Ovaries are more vulnerable than hepatocytes for insulin resistance and hyperinsulinemia
(Turk J Gastroenterol 2016; 27: 62-67)
DOI: 10.5152/tjg.2015.150473
The association between insulin resistance and hepatic fibrosis in patients with chronic hepatitis C: An observational, multicenter study in Turkey
(Turk J Gastroenterol 2014; 25: 546-552)
DOI: 10.5152/tjg.2014.7829
Gastrointestinal Tract - Original Article
Is glycogenic acanthosis a predictor of insulin resistance and metabolic syndrome?
(Turk J Gastroenterol 2017; 28: 337-341)
DOI: 10.5152/tjg.2017.17159
Liver - Original Article
Real-life results of treatment with ombitasvir, paritaprevir, dasabuvir, and ritonavir combination in patients with chronic renal failure infected with HCV in Turkey
(Turk J Gastroenterol 2019; 30: 331-335)
DOI: 10.5152/tjg.2018.18269
Assessing the outcome of patients with liver cirrhosis during hospital stay: A comparison of lymphocyte/monocyte ratio with MELD and Child-Pugh scores
(Turk J Gastroenterol 2018; 29: 308-315)
DOI: 10.5152/tjg.2018.17631
Insulin/high-density lipoprotein cholesterol ratio: A newly-discovered predictor of esophageal varices in patients with hepatitis C virus-related cirrhosis in the absence of diabetes mellitus
(Turk J Gastroenterol 2019; 30: 155-162)
DOI: 10.5152/tjg.2018.18237
Does steatosis affect the performance of diffusion-weighted MRI values for fibrosis evaluation in patients with chronic hepatitis C genotype 4?
(Turk J Gastroenterol 2017; 28: 283-288)
DOI: 10.5152/tjg.2017.16640
Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study
(Turk J Gastroenterol 2018; 29: 464-472)
DOI: 10.5152/tjg.2018.16597
Poster
Real-world efficacy, safety and clinical outcomes of ombitasvir/ paritaprevir/ ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: Turkey experience
(Turk J Gastroenterol 2019; 30: 10-15)
DOI: 10.5152/tjg.2019.07
Validation of ELF test score for hepatic fibrosis and evaluation in turkish chronic liver disease patients
(Turk J Gastroenterol 2019; 30: 29-29)
DOI: 10.5152/tjg.2019.16
Successfully treatment of chronic hepatitis C with direct-acting antiviral agents: a single center experience
(Turk J Gastroenterol 2019; 30: 34-34)
DOI: 10.5152/tjg.2019.20
Jobert syndrome ‘’ a rare cause of liver dysfunction’’
(Turk J Gastroenterol 2019; 30: 42-42)
DOI: 10.5152/tjg.2019.27
Prevalence of the potential drug-drug interactions between pangenotypic direct-acting antivirals and the concomitant medication with patients with chronic hepatitis C virus infection
(Turk J Gastroenterol 2019; 30: 43-45)
DOI: 10.5152/tjg.2019.28
Key Words
Authors
All
Reviewer's Corner
Author’s Corner
Survey
AVES | Copyright © 2019 Turkish Society of Gastroenterology | Latest Update: 04.07.2019